Radiomics and radiogenomics in ovarian cancer: a literature review.
Ovarian cancer remains one of the most lethal gynecological cancers in the world despite extensive progress in the areas of chemotherapy and surgery. Many studies have postulated that this is because of the profound heterogeneity that underpins response to therapy and prognosis. Standard imaging eva...
| Publicado en: | Abdominal Radiology Vol. 46; no. 6; pp. 2308 - 2323 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150935435&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 150935435 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2366004X JT14 jtl: Abdominal Radiology issn: 2366004X maglogo: N pubinfo: dt: Jun2021 vid: 46 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 150935435 146944371 10.1007/s00261-020-02820-z 150935435 ppf: 2308 ppct: 15 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Radiomics and radiogenomics in ovarian cancer: a literature review. aug: au: Nougaret, S. McCague, Cathal Tibermacine, Hichem Vargas, Hebert Alberto Rizzo, Stefania Sala, E. affil: IRCM, Montpellier Cancer Research Institute, INSERM, U1194, University of Montpellier, 208 Ave des Apothicaires, 34295, Montpellier, France sug: ab: Ovarian cancer remains one of the most lethal gynecological cancers in the world despite extensive progress in the areas of chemotherapy and surgery. Many studies have postulated that this is because of the profound heterogeneity that underpins response to therapy and prognosis. Standard imaging evaluation using CT or MRI does not take into account this tumoral heterogeneity especially in advanced stages with peritoneal carcinomatosis. As such, newly emergent fields in the assessment of tumor heterogeneity have been proposed using radiomics to evaluate the whole tumor burden heterogeneity as opposed to single biopsy sampling. This review provides an overview of radiomics, radiogenomics, and proteomics and examines the use of these newly emergent fields in assessing tumor heterogeneity and its implications in ovarian cancer. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|